Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Oct;18(4):573–579. doi: 10.1111/j.1365-2125.1984.tb02506.x

Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasma.

G Olsson, M Daleskog, P Hjemdahl, N Rehnqvist
PMCID: PMC1463612  PMID: 6487497

Abstract

Noradrenaline plasma kinetics were assessed in 17 male patients, who had been treated with metoprolol 100-200 mg daily (n = 8) or placebo for 3 years after an acute myocardial infarction, before and 1 week after gradual withdrawal (during 1 week) of the study treatment. Endogenous noradrenaline concentrations in plasma were measured by high performance liquid chromatography. Noradrenaline spillover rate, plasma clearance and the t1/2 for the rapid removal from plasma were determined by radio-tracer methodology. During treatment the plasma noradrenaline concentrations and noradrenaline plasma kinetic variables were similar in the two groups. Venous plasma noradrenaline concentrations were more closely correlated to the spillover rates of noradrenaline to plasma than to the clearance of noradrenaline from plasma, but the spillover rates were correlated to the clearance rates. Following the withdrawal of metoprolol noradrenaline clearance from plasma increased slightly (by 18 +/- 5%, P less than 0.05), but the plasma concentrations and spillover rates of noradrenaline were unchanged. In the placebo group withdrawal did not result in any significant changes. Our results indicate that a generalised increase in sympathetic nerve activity is not the cause of so-called rebound phenomena following withdrawal of chronic beta-adrenoceptor blockade.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boudoulas H., Lewis R. P., Kates R. E., Dalamangas G. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Intern Med. 1977 Oct;87(4):433–436. doi: 10.7326/0003-4819-87-4-433. [DOI] [PubMed] [Google Scholar]
  2. Esler M. Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci (Lond) 1982 Mar;62(3):247–254. doi: 10.1042/cs0620247. [DOI] [PubMed] [Google Scholar]
  3. Esler M., Jackman G., Bobik A., Kelleher D., Jennings G., Leonard P., Skews H., Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979 Oct 22;25(17):1461–1470. doi: 10.1016/0024-3205(79)90371-0. [DOI] [PubMed] [Google Scholar]
  4. Esler M., Jackman G., Leonard P., Skews H., Bobik A., Jennings G. Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. Br J Clin Pharmacol. 1981 Sep;12(3):375–380. doi: 10.1111/j.1365-2125.1981.tb01229.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Folkow B., Di Bona G. F., Hjemdahl P., Torén P. H., Wallin B. G. Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension. 1983 Jul-Aug;5(4):399–403. doi: 10.1161/01.hyp.5.4.399. [DOI] [PubMed] [Google Scholar]
  6. Goldstein D. S. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Am J Cardiol. 1981 Dec;48(6):1147–1154. doi: 10.1016/0002-9149(81)90333-7. [DOI] [PubMed] [Google Scholar]
  7. Hansen J. F., Hesse B., Christensen N. J. Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise. Eur J Clin Invest. 1978 Feb;8(1):31–36. doi: 10.1111/j.1365-2362.1978.tb00805.x. [DOI] [PubMed] [Google Scholar]
  8. Hansson B. G., Dymling J. F., Manhem P., Hökfelt B. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate. Eur J Clin Pharmacol. 1977 Apr 20;11(4):247–254. doi: 10.1007/BF00607672. [DOI] [PubMed] [Google Scholar]
  9. Hjemdahl P., Akerstedt T., Pollare T., Gillberg M. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl. 1983;515:45–53. [PubMed] [Google Scholar]
  10. Hjemdahl P., Daleskog M., Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979 Jul 9;25(2):131–138. doi: 10.1016/0024-3205(79)90384-9. [DOI] [PubMed] [Google Scholar]
  11. Hjemdahl P., Freyschuss U., Juhlin-Dannfelt A., Linde B. Differentiated sympathetic activation during mental stress evoked by the Stroop test. Acta Physiol Scand Suppl. 1984;527:25–29. [PubMed] [Google Scholar]
  12. Lijnen P. J., Amery A. K., Fagard R. H., Reybrouck T. M., Moerman E. J., De Schaepdryver A. F. The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise. Br J Clin Pharmacol. 1979 Feb;7(2):175–181. doi: 10.1111/j.1365-2125.1979.tb00918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Man in 't Veld A. J., Schalekamp M. A. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol. 1982;13(Suppl 2):245S–257S. doi: 10.1111/j.1365-2125.1982.tb01922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morganti A., Pickering T. G., Lopez-Ovejero J. A., Laragh J. H. Contrasting effects of acute beta blockade with propranolol on plasma catecholamines and renin in essential hypertension: a possible basis for the delayed antihypertensive response. Am Heart J. 1979 Oct;98(4):490–494. doi: 10.1016/0002-8703(79)90255-2. [DOI] [PubMed] [Google Scholar]
  15. Nattel S., Rangno R. E., Van Loon G. Mechanism of propranolol withdrawal phenomena. Circulation. 1979 Jun;59(6):1158–1164. doi: 10.1161/01.cir.59.6.1158. [DOI] [PubMed] [Google Scholar]
  16. Olsson G., Rehnqvist N., Lundman T., Melcher A. Metoprolol treatment after acute myocardial infarction. Effects on ventricular arrhythmias and exercise tests during 6 months. Acta Med Scand. 1981;210(1-2):59–65. [PubMed] [Google Scholar]
  17. Planz G., Planz R. Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise. Eur J Clin Pharmacol. 1981 Jan;19(2):83–88. doi: 10.1007/BF00568393. [DOI] [PubMed] [Google Scholar]
  18. Rahn K. H., Gierlichs H. W., Planz G., Planz R., Schols M., Stephany W. Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension. Eur J Clin Invest. 1978 Jun;8(3):143–148. doi: 10.1111/j.1365-2362.1978.tb00827.x. [DOI] [PubMed] [Google Scholar]
  19. Rangno R. E., Langlois S., Lutterodt A. Metoprolol withdrawal phenomena: mechanism and prevention. Clin Pharmacol Ther. 1982 Jan;31(1):8–15. doi: 10.1038/clpt.1982.2. [DOI] [PubMed] [Google Scholar]
  20. Rangno R. E., Langlois S., Stewart J. Cardiac hyper- and hyporesponsiveness after pindolol withdrawal. Clin Pharmacol Ther. 1982 May;31(5):564–571. doi: 10.1038/clpt.1982.79. [DOI] [PubMed] [Google Scholar]
  21. Ross P. J., Lewis M. J., Sheridan D. J., Henderson A. H. Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J. 1981 Jun;45(6):637–642. doi: 10.1136/hrt.45.6.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vandongen R., Davidson L., Beilin L. J., Barden A. E. Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects. Br J Clin Pharmacol. 1981 Sep;12(3):369–374. doi: 10.1111/j.1365-2125.1981.tb01228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vlachakis N. D. Blood pressure variability and plasma catecholamines in man. Effect of propranolol therapy. Biochem Med. 1979 Jun;21(3):253–261. doi: 10.1016/0006-2944(79)90080-2. [DOI] [PubMed] [Google Scholar]
  24. Watson R. D., Eriksson B. M., Hamilton C. A., Reid J. L., Stallard T. J., Littler W. A. Effects of chronic beta-adrenoceptor antagonism on plasma catecholamines and blood pressure in hypertension. J Cardiovasc Pharmacol. 1980 Nov-Dec;2(6):725–738. doi: 10.1097/00005344-198011000-00003. [DOI] [PubMed] [Google Scholar]
  25. de Leeuw P. W., Falke H. E., Kho T. L., Vandongen R., Wester A., Birkenhäger W. H. Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. Acta Med Scand. 1977;202(5):389–392. doi: 10.1111/j.0954-6820.1977.tb16849.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES